TrialJournal of neurology2005

Comparative tolerance of IFN beta-1a regimens in patients with relapsing multiple sclerosis. The EVIDENCE study.

M Sandberg-Wollheim et al.PubMed ↗Publisher ↗

No numbers read from the abstract.